Fund Holdings — Finepoint Capital LP

Total Portfolio Value
$592.81M
Total Bought
$0
Total Sold
$289.26M
Net Transaction
-$289.26M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
SPRINGWORKS THERAPEUTICS INC748,752728,602-20,15027,05232,1535.42%+5,101
ASCENDIS PHARMA A/S(ASND)184,872179,872-5,00025,45128,0354.73%+2,584
Marblegate Acquisition Corp735,000735,0000261180.02%+92
ALEANNA INC(ANNA)490,000490,0000691220.02%+54
ALEANNA INC(ANNA)27,71727,71701972090.04%+12
CALIDI BIOTHERAPEUTICS INC12,50012,499-11470.00%-7
MONEYHERO LIMITED
*W EXP 09/13/202
895,000895,000049330.01%-17
LAKESHORE BIOPHARMA CO LTD489,999489,999049200.00%-28
AVIDITY BIOSCIENCES INC391,300380,700-10,60011,37911,2381.90%-141
SOLID BIOSCIENCES INC961,251961,25103,8453,5570.60%-288
PROTHENA CORP PLC
SHS
657,071640,071-17,0009,1007,9211.34%-1,180
GALAPAGOS NV(LKFT)674,762656,587-18,17518,55616,4932.78%-2,062
EYEPOINT PHARMACEUTICALS INC(EYPT)1,111,1041,081,954-29,1508,2785,8640.99%-2,414
CYTOKINETICS INC(CYTK)318,448309,948-8,50014,98012,4572.10%-2,523
RELAY THERAPEUTICS INC(RLAY)2,175,6462,117,646-58,0008,9645,5480.94%-3,415
REVOLUTION MEDICINES INC(RVMD)710,260691,260-19,00031,06724,4434.12%-6,624
MoonLake Immunotherapeutics(MLTX)447,935435,785-12,15024,25617,0262.87%-7,230
XENCOR INC(XNCR)660,000642,200-17,80015,1676,8331.15%-8,334
ARVINAS INC(ARVN)713,778694,028-19,75013,6834,8720.82%-8,811
SAREPTA THERAPEUTICS INC(SRPT)161,935157,555-4,38019,69010,0551.70%-9,635
LIBERTY MEDIA CORP DEL812,792432,895-379,89755,31929,4974.98%-25,821
Argenx SE(ARGX)52,9280-52,92832,5510—-32,551
QXO INC(QXO)24,933,82524,468,160-465,665396,448331,29955.89%-65,149
Liberty Broadband Corp(LBRDA)2,015,710529,240-1,486,470150,69445,0127.59%-105,683
Page 1 of 1
Finepoint Capital LP — 13F Holdings — Q1 2025 | TickerTrail